More on Darwin's illness: comment on the final diagnosis of Charles Darwin

Syndrome du jour: The historiography and moral implications of Diagnosing Darwin

Diagnosing Darwin's health problems has a long history. Innumerable diagnoses have been proffered in letters, articles, and a handful of dedicated books. Diagnostic speculation has exhibited contrasting somatogenic or psychogenic preferences. Psychogenic accounts dominated mid-century but were soon challenged by somatic explanations citing specific infectious or toxic aetiologies. This tension remains, although psychogenic accounts have tended to be swamped by an array of somatogenic diagnoses championed by biomedical specialists. As a whole, this parade of diagnoses has a striking syndrome du jour quality. Successive conjectures speak of the preoccupations and diagnostic fads of their particular age. Moreover, for many participants in this diagnostic game, unconscious presentism combined with self-serving projection, turning the question of what ailed Darwin into something of a Rorschach test. Never far from the surface was a sometimes-fraught tussle over the man's reputation, animated by the moral valences of the conjectures in play. In a broader sense, this diagnostic game has shaped biographical accounts of Darwin and his career in some significant ways.

Bacterial metabolic 'toxins': a new mechanism for lactose and food intolerance, and irritable bowel syndrome

Lactose and food intolerance cause a wide range of gut and systemic symptoms, including gas, gut pain, diarrhoea or constipation, severe headaches, severe fatigue, loss of cognitive functions such as concentration, memory and reasoning, muscle and joint pain, heart palpitations, and a variety of allergies (Matthews and Campbell, 2000; Matthews et al., 2005; Waud et al., 2008). These can be explained by the production of toxic metabolites from gut bacteria, as a result of anaerobic digestion of carbohydrates and other foods, not absorbed in the small intestine. These metabolites include alcohols, diols such as butan 2,3 diol, ketones, acids, and aldehydes such as methylglyoxal (Campbell et al., 2005, 2009). These 'toxins' induce calcium signals in bacteria and affect their growth, thereby acting to modify the balance of microflora in the gut (Campbell et al., 2004, 2007a,b). These bacterial 'toxins' also affect signalling mechanisms in cells around the body, thereby explaining the wide range of symptoms in people with food intolerance. This new mechanism also explains the most common referral to gastroenterologists, irritable bowel syndrome (IBS), and the illness that afflicted Charles Darwin for 50 years (Campbell and Matthews, 2005a,b). We propose it will lead to a new understanding of the molecular mechanism of type 2 diabetes and some cancers.